Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium

Journal of Oral Pathology and Medicine

Volumn 35, Issue 8, 2006, Pages 484-491

  Jayatilake, J A M S ^a,b   Samaranayake, Y H ^b   Cheung, L K ^c   Samaranayake, L P ^b  

^a UNIVERSITY OF PERADENIYA   (Sri Lanka)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Candida species; Image analysis; Oral candidiasis; Reconstituted human oral epithelium

Indexed keywords

ASPARTIC PROTEINASE; SECRETORY ASPARTIC PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CAMERA; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL INVASION; COMPUTER PROGRAM; CONTROLLED STUDY; ENZYME SYNTHESIS; FUNGAL VIRULENCE; FUNGUS HYPHAE; FUNGUS MUTANT; FUNGUS SPORE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MODEL; MORPHOGENESIS; MOUTH MUCOSA; NONHUMAN; PATHOGENESIS; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THRUSH;

ASPARTIC ENDOPEPTIDASES; CANDIDA ALBICANS; CANDIDIASIS, ORAL; EPITHELIUM; FUNGAL PROTEINS; HUMANS; HYPHAE; STATISTICS, NONPARAMETRIC;

EID: 33747040246     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00435.x     Document Type: Article

References (34)

1. Samaranayake LP. Host factors and oral candidosis. In: Samaranayake LP, Macfarlane TW, eds. Oral candidosis. London, UK: Butterworth & Co (Publishers) Ltd, 1990; 66-103.
2. Arendorf TM, Walker DM. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980; 25: 1-10.
3. Colombo AL, Perfect J, DiNubile M, et al. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur J Clin Microbiol Infect Dis 2003; 22: 470-4.
4. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239-44.
5. Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev 2001; 14: 398-429.
6. Pemberton J, Turner EP. Organ culture model to study tissue invasion by Candida albicans. J Dent Res 1973; 52: 948.
7. Borg M, Ruchel R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun 1988; 56: 626-31.
8. Howlett JA. The infection of rat tongue mucosa in vitro with five species of Candida. J Med Microbiol 1976; 9: 309-16.
9. Partridge BM, Ather MA, Winner HI. Chick embryo inoculation as a pathogenicity test for Candida species. J Clin Pathol 1971; 24: 645-8.
10. Shimizu K, Kondoh Y, Tanaka K. Proteinase production and pathogenicity of Candida albicans, invasion into chorioallantoic membrane by C. albicans strains of different proteinase activity. Microbiol Immunol 1987; 31: 1045-60.
11. Gow NAR, Knox Y, Munro CA, Thompson WD. Infection of chick chorioallantoic membrane (CAM) as a model for invasive hyphal growth and pathogenesis of Candida albicans. Med Mycol 2003; 41: 331-8.
12. Bartie KL, Williams DW, Wilson MJ, Potts AJC, Lewis MAO. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol 2004; 19: 293-6.
13. Bernhardt J, Herman D, Sheridan M, Calderone R. Adherence and invasion studies of Candida albicans strains using in vitro models of esophageal candidiasis. J Infect Dis 2001; 184: 1170-5.
14. Bonowitz A, Schaller M, Laude J, Reimer K, Korting HC. Comparative therapeutic and toxic effects of different providone iodine (PVP-1) formulations in a model of oral candidosis based on in vitro reconstituted epithelium. J Drug Target 2001; 9: 75-83.
15. Jayatilake JAMS, Samaranayake YH, Samaranayake LP. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J Oral Pathol Med 2005; 34: 240-6.
16. Schaller M, Schafer W, Korting HC, Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 1998; 29: 605-15.
17. Schaller M, Korting HC, Schafer W, Bastert J, Chen WC, Hube B. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 1999; 34: 169-80.
18. Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B, Korting HC. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 2002; 118: 652-7.
19. Butz-Jogensen E. Histopathology, immunology and serology of oral yeast infections: diagnosis of oral candidosis. Acta Odontol Scand 1990; 48: 37-43.
20. Sobel JD, Muller G, McCormick JF. Experimental chronic vaginal candidosis in rats. Sabouraudia 1985; 23: 199-206.
21. Cole GT, Seshan KR, Pope LM, Yancey RJ. Morphological aspects of gastrointestinal tract invasion by Candida albicans in the infant mouse. J Med Vet Mycol 1988; 26: 173-85.
22. Allen CM, Paulson R, Duncan R. Clinical, histologic and scanning electron microscopic study of the development of chronic candidiasis of the rat tongue. J Oral Pathol Med 1989; 18: 352-9.
23. O'Day DM, Head WS, Csank C, et al. Differences in virulence between two Candida albicans strains in experimental keratitis. Invest Ophthalmol Vis Sci 2000; 41: 1116-21.
24. O'Day DM, Head WS, Robinson RD, Yang R, Shetlar D, Wang MX. Contact lens-induced infection - a new model of Candida albicans keratitis. Invest Ophthalmol Vis Sci 1999; 40: 1607-11.
25. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986; 15: 386-8.
26. Weibel ER. Stereological methods, practical methods for biological morphometry, Vol. 1. London, UK: Academic press Inc. (London) Ltd, 1979.
27. Lepidi H, Fournier PE, Raoult D. Quantitative analysis of valvular lesions during Bartonella endocarditis. Am J Clin Pathol 2000; 114: 880-9.
28. Lepidi H, Fenollar F, Gerolami R, et al. Whipple's disease: immunospecific and quantitative immunohistochemical study of intestinal biopsy specimens. Hum Pathol 2003; 34: 589-96.
29. Stevens A, Francis RF. Micro-organisms. In: Bancroft J, Stevens A, eds. Theory and practice of histological techniques. New York, USA: Churchill Livingstone, 1996; 291-308.
30. Arendrup M, Horn N, Frimodt-Moller N. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 2002; 30: 286-91.
31. Hurley R, Stanley VC. Cytopathic effects of pathogenic and non-pathogenic species of Candida on cultured mouse epithelial cells: relation to the growth rate and morphology of the fungi. J Med Microbiol 1969; 2: 63-74.
32. Dieterich C, Schandar M, Noll M, et al. In vitro reconstructed human epithelia reveal contributions of Candida albicans EFG1 and CPH1 to adhesion and invasion. Microbiology 2002; 148: 497-506.
33. Felk A, Kretschmar M, Albrecht A, et al. Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun 2002; 70: 3689-700.
34. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003; 67: 400-28.